SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0000950123-98-002825
Filing Date
1998-03-24
Accepted
1998-03-24 00:00:00
Documents
12
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 BIOCHEM PHARMA INC. F-3 336222
2 ARTICLES OF INCORPORATION EX-3.1 6213
3 BY-LAWS EX-3.2 55626
4 ARTICLES OF AMENDMENT EX-3.3 33474
5 TECHNOLOGY LICENSE AGREEMENT EX-10.1 57305
6 RESEARCH AND DEVELOPMENT AGREEMENT EX-10.2 44286
7 PRODUCT OPTION AGREEMENT EX-10.3 44294
8 FORM OF DISTRIBUTION AGREEMENT EX-10.4 26381
9 FORM OF SERVICES AGREEMENT EX-10.5 19864
10 CONSENT OF ERNST & YOUNG, RE: CLINICHEM EX-23.1 511
11 FINANCIAL DATA SCHEDULE EX-27.1 2398
12 FORM OF OPINION OF MERRILL LYNCH, PIERCE, ET AL. EX-99.1 6793
  Complete submission text file 0000950123-98-002825.txt   635903
Mailing Address 275 ARMAND FRAPPIER BLVD LAVAL QUEBEC E6
Business Address 275 ARMAND-FRAPPIER BLVD LAVAL QUEBEC E6 5146811744
BIOCHEM PHARMA INC (Filer) CIK: 0000867202 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E6 | Fiscal Year End: 0131
Type: F-3 | Act: 33 | File No.: 333-48521 | Film No.: 98571657
SIC: 2835 In Vitro & In Vivo Diagnostic Substances